New Zealand - English - Ministry for Primary Industries

arxada nz limited - pyrimethanil; fluazinam - pyrimethanil 320 g/litre; fluazinam 200 g/litre - fungicide

Australia - English - Department of Health (Therapeutic Goods Administration)

corin australia pty ltd - 32831 - uncoated knee femur prosthesis - the apex knee system ps femur cemented component is designed for use in the apex primary knee system only to replace the femoral condyles of the patient and articulate against tibial insert. the device retains a deep patella groove and offers 80 degrees of uninterrupted patella tracking along the trochlear groove. the non-porous coated femoral component is made from cocr alloy and is used cemented only. the apex knee system ps femur cemented is a component of the apex primary knee system intended to repair or replace the patient?s femoral knee joint or revision total knee replacement. this prosthesis is intended for cemented use only in the apex primary knee system and may be used for the following conditions as appropriate: o non-inflammatory degenerative joint disease, including osteoarthritis and avascular necrosis; o rheumatoid arthritis; o correction of functional deformity and o revision procedures where other treatments or devices have failed.

Australia - English - Department of Health (Therapeutic Goods Administration)

corin australia pty ltd - 46585 - prosthesis, knee, internal, insert component - the apex primary knee system congruent tibial insert cruciate retaining component is designed to attach to the tibial baseplate of the apex primary knee system and replace the tibial articular surface of the patient. the device is made from uhmwpe and is intended for use only in the apex primary knee system and where the cruciate ligament is intact. the apex primary knee system congruent tibial insert cruciate retaining is a component of the apex knee system intended to replace the tibial articular surface in a primary or revision total knee replacement. the congruent tibial insert is used in knee joint replacement surgery where the cruciate ligament is intact. this prosthesis may be used for the following conditions, as appropriate: o non-inflammatory degenerative joint disease, including osteoarthritis and avascular necrosis; o rheumatoid arthritis; o correction of functional deformity and o revision procedures where other treatments or devices have failed.

Australia - English - Department of Health (Therapeutic Goods Administration)

corin australia pty ltd - 34199 - polyethylene patella prosthesis - the apex primary knee all poly patella 3 peg component is designed to replace the patella articular surface of the patient. it articulates against the femoral component in the apex primary knee system. the device is made from uhmwpe and is intended for cemented use in the apex primary knee system only. the apex primary knee all poly patella 3 peg is a component of the apex knee system intended to replace the patella articular surface of the knee joint in a primary or revision total knee replacement. this prosthesis may be used for the following conditions as appropriate: o non-inflammatory degenerative joint disease, including osteoarthritis and avascular necrosis; o rheumatoid arthritis; o correction of functional deformity and o revision procedures where other treatments or devices have failed.

Australia - English - Department of Health (Therapeutic Goods Administration)

corin australia pty ltd - 32832 - uncoated knee tibia prosthesis, metallic - the apex primary knee system tibial baseplate non-porous cemented component is designed for use in the apex primary knee system only. the non-porous coated tibia component is designed to replace the tibial condyles of the patient and provides a platform to attach the articulating tibial insert. the device is made from cocr and is used cemented only. the apex primary knee system tibial baseplate non-porous cemented is a component of the apex primary knee system intended to repair or replace the tibial condyles of the knee joint in a primary or revision total knee replacement. this prosthesis is intended for cemented use only in the apex primary knee system and may be used for the following conditions, as appropriate: o non-inflammatory degenerative joint disease, including osteoarthritis and avascular necrosis; o rheumatoid arthritis; o correction of functional deformity and o revision procedures where other treatments or devices have failed.

Australia - English - Department of Health (Therapeutic Goods Administration)

corin australia pty ltd - 32831 - uncoated knee femur prosthesis - the apex primary knee system cr femoral non porous cemented component is designed for use in the apex primary knee system only. the device is made from cocr. it retains a deep wide patella groove, has been designed with high flex geometry, and has a generously curved sagittal geometry that eliminates edge loading during varus/valgus lift off. the apex primary knee system cr femoral non porous cemented is a component of the apex knee system intended to repair or replace the patient?s femoral knee joint in a primary or revision total knee replacement. this prosthesis may be used for the following conditions, as appropriate: ? non-inflammatory degenerative joint disease, including osteoarthritis and avascular necrosis; ? rheumatoid arthritis; ? correction of functional deformity; ? revision procedures where other treatments or devices have failed

Australia - English - Department of Health (Therapeutic Goods Administration)

kerr australia pty ltd - 16355 - apex locator, endodontic - a medical device designed for use in measuring the working length of root canals.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

boehringer ingelheim ltd - pramipexole dihydrochloride monohydrate - tablet - 700microgram

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

boehringer ingelheim ltd - pramipexole dihydrochloride monohydrate - tablet - 180microgram

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

boehringer ingelheim ltd - pramipexole dihydrochloride monohydrate - tablet - 88microgram